PROACT Patient Reported Opinions about Clinical Tolerability

• Research type

  Research Study

• Full title

  A pilot to study the uptake of mobile technology, how this may enhance 2 way communication between a patient and their medical team, and assess the potential benefit of a Sponsor understanding the patient’s perspective on tolerability issues.

• IRAS ID

  150149

• Contact name

  Hendrik-Tobias Arkenau

• Contact email

  Tobias.Arkenau@hcahealthcare.co.uk

• Sponsor organisation

  AstraZeneca

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  14/EE/0114

• Date of REC Opinion

  18 Mar 2014

• REC opinion

  Favourable Opinion